Emergent BioSolutions Inc (NYSE:EBS)
$ 12.01 0.24 (2.04%) Market Cap: 650.75 Mil Enterprise Value: 1.43 Bil PE Ratio: 0 PB Ratio: 1.65 GF Score: 68/100

Emergent BioSolutions Inc at Cowen Healthcare Conference (Virtual) Transcript

Mar 01, 2021 / 05:20PM GMT
Release Date Price: $102.2 (+6.46%)
Boris Peaker
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Well, welcome, everybody, and thank you for joining our discussion with Emergent BioSolutions. Let's just dive right in since we only have 0.5 hour here.

Questions & Answers

Boris Peaker
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

There's been a lot of interest in your CDMO business certainly over the last year. And so maybe start with Bob. Can you talk a little bit about the history of the CDMO business, how it came to be the folks of organization? How should investors be thinking about it? Maybe talk a little about some of the backlog and some of the new metrics you've provided for investors to better understand the business. And how should we be thinking about it several years in the future?

Robert G. Kramer
Emergent BioSolutions Inc. - CEO, President & Executive Director

Sure. So first of all, Boris, thanks for the opportunity to participate in the conference. Good to see

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot